Veru Market Share Analysis for June 2026

Get in touch with Veru Inc. for general inquiries, product inquiries, or investor inquiries via email, phone, or form submission.

Health > Biotechnology and Pharmaceuticals

Domainverupharma.com

Year Founded1971

Employees201 - 500

Annual Revenue$25M - $50M

Veru

Veru (including company regionals)

verupharma.com

See more website traffic and engagement information

Veru Revenue up to June 2026 is 25M - 50M

revenue generated by Veru top domains

Veru top domains revenue over 3 years

Revenue for Veru top domains

verupharma.com25M - 50M

See more with Sales Intelligence

Total visits to Veru's top domains

Understand Veru market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

verupharma.com5K

See more with Sales Intelligence

Avg. visit duration in Veru's top domains

Analyze Veru engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

verupharma.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Veru's top domains

See how Veru keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

verupharma.com1.88

See more with Sales Intelligence

Veru top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Veru

These are the website technologies, by industry, used by Veru top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (6)

WooCommerce

Widget (6)

Twemoji

Advertising (4)

DoubleClick

More Technologies

11

See all

News & Signals from Veru

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVeru Inc. is developing GLP-1-based drugs to treat obesity and diabetes.Viking Therapeutics, Terna Pharmaceuticals, Eccogene, and Veru Inc. are the emerging biotechnology firms developing GLP-1-based drugs to treat obesity and diabetes.

NewsVeru Inc. attends event Jones Healthcare and Technology Innovation Conference.With a keen focus on innovative treatments for cardiometabolic and inflammatory diseases, Veru Inc. is set to have an insightful presence at the Jones Healthcare and Technology Innovation Conference.

NewsVeru Inc. hires Steven B. Heymsfield M.D. as Principal Investigator.Veru announces Steven B. Heymsfield M.D. as the Principal Investigator for its enobosarm Phase 2b clinical trial for high quality weight loss.